EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seroprevalence and Determinants of SARS-CoV-2 Antibodies Among Healthcare Workers in Dar es Salaam, Tanzania

Erick Alexander Mboya, Claudia Hawkins, Doreen Kamori, Davis Elias Amani, Grace Shayo, Raphael Z. Sangeda, Joan Rugemalila, Faraja Chiwanga, Sabina Mugusi, Upendo Nkwera, Patricia Munseri, Mangaro Mabusi und 5 weitere

COVID · 18.11.2026 · 6 (11) · 205

DOI: 10.3390/covid6110205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift COVID, online erschienen am 18.11.2026. Verfasst von Erick Alexander Mboya und 16 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Muhimbili University of Health and Allied Sciences, Robert J. Havey, MD Institute for Global Health Research Catalyzer Award, Northwestern’s Global Health Initiative.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies from the Sub-Saharan African (SSA) countries suggest an underestimate of SARS-CoV-2 infections during the pandemic. We investigated the seroprevalence and factors associated with anti-SARS CoV-2 seropositivity among healthcare workers (HCWs) in Dar es Salaam, Tanzania. We conducted a cross-sectional study in three tertiary hospitals in Dar es Salaam among randomly selected HCWs between October 2021 and March 2022. Demographic and SARS-CoV-2-related exposures were collected as well as blood for Immunoglobulin G (IgG) against SARS-CoV-2 nucleocapsid (IgG-N) or spike (IgG-S) proteins using WHO/FDA-pre-qualified SARS-CoV-2 ELISA test kits. Descriptive statistics were used to determine the SARS-CoV-2 antibody prevalence. Multivariable Modified Poisson regression was used to determine the association between HCWs characteristics and SARS-CoV-2 serologic status. Of the 394 participants [mean age (SD) of 37.9 (9.8) years] included, 327 (83%) had never been tested for COVID-19 before the study and 148 (37.6%) had received at least one dose vaccine against COVID-19 at enrolment. The overall seroprevalence of SARS-CoV-2 IgG (including IgG-N, IgG-S or both) was 90.9% (95% CI: 76.7–96.8%). HCWs who had at least one dose of vaccine against COVID-19 were 13% more likely to be seropositive than those who were not vaccinated (aPR = 1.13 (95% CI: 1.02–1.25; p = 0.023). HCWs who believed they had COVID-19 but never tested had 9% higher seroprevalence compared to those who believed they never had COVID-19 (aPR = 1.09; 95% CI: 1.03–1.16; p = 0.003). HCWs working in the laboratory, anesthesia and obstetrics and gynecology departments were more likely to have SARS-CoV-2 antibodies than HCWs from the emergency medicine department (EMD). The seroprevalence of anti-SARS-CoV-2 IgG among HCWs in this study was high despite low vaccine coverage in this population indicating high SARS-CoV-2 exposure among HCWs. Our work highlights the need for more effective infection control practices in healthcare settings in future pandemics like these, especially among HCWs at highest risk.

Förderung

  • Muhimbili University of Health and Allied Sciences
  • Robert J. Havey, MD Institute for Global Health Research Catalyzer Award
  • Northwestern’s Global Health Initiative
  • Northwestern Medicine Primary and Specialty Care

Zitieren

APA

Mboya, E. A., Hawkins, C., Kamori, D., Amani, D. E., Shayo, G., Sangeda, R. Z., Rugemalila, J., Chiwanga, F., Mugusi, S., Nkwera, U., Munseri, P., Mabusi, M., Aboud, S., Mugusi, F., Sunguya, B., Bakari, M., & Nagu, T. (2026). Seroprevalence and Determinants of SARS-CoV-2 Antibodies Among Healthcare Workers in Dar es Salaam, Tanzania. COVID, 6(11), 205. https://doi.org/10.3390/covid6110205

Vancouver

Mboya EA, Hawkins C, Kamori D, Amani DE, Shayo G, Sangeda RZ, et al. Seroprevalence and Determinants of SARS-CoV-2 Antibodies Among Healthcare Workers in Dar es Salaam, Tanzania. COVID. 2026;6(11):205. doi:10.3390/covid6110205

BibTeX
@article{Mboya2026,
  author = {Mboya, Erick Alexander and Hawkins, Claudia and Kamori, Doreen and Amani, Davis Elias and Shayo, Grace and Sangeda, Raphael Z. and Rugemalila, Joan and Chiwanga, Faraja and Mugusi, Sabina and Nkwera, Upendo and Munseri, Patricia and Mabusi, Mangaro and Aboud, Said and Mugusi, Ferdinand and Sunguya, Bruno and Bakari, Muhammad and Nagu, Tumaini},
  title = {Seroprevalence and Determinants of SARS-CoV-2 Antibodies Among Healthcare Workers in Dar es Salaam, Tanzania},
  journal = {COVID},
  year = {2026},
  volume = {6},
  number = {11},
  pages = {205},
  doi = {10.3390/covid6110205}
}
Kostenlos starten →